Correlation Between Effector Therapeutics and AstraZeneca PLC
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Effector Therapeutics and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and AstraZeneca PLC.
Diversification Opportunities for Effector Therapeutics and AstraZeneca PLC
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Effector and AstraZeneca is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between Effector Therapeutics and AstraZeneca PLC
Given the investment horizon of 90 days Effector Therapeutics is expected to under-perform the AstraZeneca PLC. In addition to that, Effector Therapeutics is 8.89 times more volatile than AstraZeneca PLC ADR. It trades about -0.06 of its total potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about 0.21 per unit of volatility. If you would invest 6,415 in AstraZeneca PLC ADR on February 4, 2024 and sell it today you would earn a total of 1,220 from holding AstraZeneca PLC ADR or generate 19.02% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Effector Therapeutics vs. AstraZeneca PLC ADR
Performance |
Timeline |
Effector Therapeutics |
AstraZeneca PLC ADR |
Effector Therapeutics and AstraZeneca PLC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Effector Therapeutics and AstraZeneca PLC
The main advantage of trading using opposite Effector Therapeutics and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
AstraZeneca PLC vs. Expensify | AstraZeneca PLC vs. Skyworks Solutions | AstraZeneca PLC vs. Large Cap Fund | AstraZeneca PLC vs. Wabash National |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |